1.
Muraleedharan T, Balan A. Integrating Immunotherapy and Targeted Therapy in Advanced Hepatocellular Carcinoma: Clinical Outcomes of Lenvatinib–Pembrolizumab Combination Therapy. Int J Med Stud [Internet]. 2026 Aug. 19 [cited 2026 Aug. 23];. Available from: https://ijms.info/IJMS/article/view/4891